Welcome to the Porton Newsroom

Newsletters 2026-07-31

Porton Newsletter - July 2026 Recap

Antibody-Oligonucleotide Conjugates: From Conjugation Strategy to Purification and Analytical Control Porton Named as a Constituent of the FTSE4Good Index Series

News 2026-07-03

Porton Delivers Dual-Payload ADC IND, Advancing Next-generation Conjugate Drug Development

Porton One-stop Biologics and Conjugates CDMO Platform successfully completed the full-cycle delivery of process development and GMP IND clinical sample manufacturing for a dual-payload ADC.

News 2026-07-02

Porton Highlights Integrated CDMO Capabilities at BIO International Convention 2026 and Celebrates Porton J-STAR's 30th Anniversary

Porton Highlights Integrated CDMO Capabilities at BIO International Convention 2026 and Celebrates Porton J-STAR’s 30th Anniversary

Newsletters 2026-06-30

Porton Newsletter - June 2026 Recap

Porton Newsletter - June 2026 Recap

News 2026-06-25

Porton Concludes Productive Presence at CPHI China 2026

Porton Pharma Solutions Ltd. (“Porton”) wrapped up a productive three-day presence at CPHI China 2026, which was held from June 16 to 18 at the Shanghai New International Expo Centre.

Newsletters 2026-05-31

Porton Newsletter - May 2026 Recap

Porton Newsletter - May 2026 Recap

Newsletters 2026-04-30

Porton Newsletter - April 2026 Recap

Porton Newsletter - April 2026 Recap

News 2026-04-03

Porton & Pliant Joint Publication in ACS Catalysis

Process Chemistry and Catalysis & Enabling Technology Teams Reported a Novel Breakthrough in Catalytic Transformation

Newsletters 2026-03-31

Porton Newsletter - March 2026 Recap

Porton Newsletter - March 2026 Recap